These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6446585)

  • 21. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
    Hong K; Kinoshita T; Kitajima H; Inoue K
    J Immunol; 1981 Jul; 127(1):104-8. PubMed ID: 7240739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of the C3b-binding entity of C3b-receptor from human erythrocytes.
    Mussel HH; Ehlen T; Schmitt M; Kazatchkine MD; Neyses L; Dierich MP
    Immunol Lett; 1982 Jan; 4(1):1-6. PubMed ID: 7061110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1).
    Hogg N; Ross GD; Jones DB; Slusarenko M; Walport MJ; Lachmann PJ
    Eur J Immunol; 1984 Mar; 14(3):236-43. PubMed ID: 6368248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of cellular Fc and C3 receptors on the complement-dependent degradation of stable soluble immunoglobulin aggregates by normal and trypsin-treated peritoneal macrophages.
    Daha MR; van Es LA
    Immunology; 1982 Sep; 47(1):203-9. PubMed ID: 7118161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immune adherence (C3b) receptor activity of erythrocytes in patients with esophageal cancer and cancer of the gastric cardia].
    Cai FQ; Jing YH; Gao YF; Yang XW; Li FZ; Zhao LQ; Xiong ML
    Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):253-5. PubMed ID: 2944730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A specific indicator for mouse lymphocyte C3b receptors.
    Linscott WD; Ranken R
    J Immunol; 1978 Jul; 121(1):221-4. PubMed ID: 670699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of beta 1H for the binding of C3b-coated particles to human lymphoid and phagocytic cells.
    Schmitt M; Mussel HH; Hammann KP; Scheiner O; Dierich MP
    Eur J Immunol; 1981 Oct; 11(10):739-45. PubMed ID: 6458499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b.
    Newman SL; Johnston RB
    J Immunol; 1979 Oct; 123(4):1839-46. PubMed ID: 573303
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on immune adherence (C3b) receptor activity of human erythrocytes: relationship between receptor activity and presence of immune complexes in serum.
    Inada Y; Kamiyama M; Kanemitsu T; Hyman CL; Clark WS
    Clin Exp Immunol; 1982 Oct; 50(1):189-97. PubMed ID: 6216998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coupling of C3b to erythrocytes by disulfide bond formation: preparation of EC3b for hemolytic and complement receptor assays.
    Lambris JD; Scheiner O; Schulz TF; Alsenz J; Dierich MP
    J Immunol Methods; 1983 Dec; 65(3):277-83. PubMed ID: 6197481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. I. Isolation and characterization of factor H: the serum cofactor for the C3b/C4b inactivator (factor I).
    Kinoshita T; Nussenzweig V
    J Immunol Methods; 1984 Jul; 71(2):247-57. PubMed ID: 6376638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rosette formation by canine peripheral blood lymphocytes.
    Bowles CA; White GS; Lucas D
    J Immunol; 1975 Jan; 114(1 Pt 2):399-402. PubMed ID: 1090659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The coagglutination phenomenon of Bordet and Gengou involves a reaction between antibody-aggregated fourth component of complement and a receptor on guniea pig red cells.
    Coombs RR; Wilson AB; Lachmann PJ
    Int Arch Allergy Appl Immunol; 1980; 61(4):371-9. PubMed ID: 6154012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of human lymphocytes with fluid phase human C3b detected by immunofluorescence.
    Simonian S; Molenaar JL; Zeijlemaker WP; Knape JT; Bakker S; Pondman KW
    Eur J Immunol; 1976 Jan; 6(1):52-6. PubMed ID: 823035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simple methods for preparing EAC1,4b,2a,3b and EAC4b,3b with human or guinea pig complement components using an anticomplementary agent, K-76 monocarboxylic acid.
    Hong K; Kinoshita T; Inoue K
    J Immunol; 1981 Jul; 127(1):109-14. PubMed ID: 6909271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.